Navigation Links
Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
Date:1/28/2009

Kensey Nash Corporation Non-GAAP Financial Measures and Reconciliations Adjusted Earnings Per Share Six Months Six Months Ended Ended Year over Year December 31, December 31, % Change 2008 2007 ------------ ------------ Earnings Per Share - GAAP $0.87 $0.19 Special Charges (a) - 0.17 ---- --- Adjusted Diluted Earnings Per Share $0.87 $0.36 142% ===== ===== === (a) Diluted earnings per share for the six months ended December 31, 2007 included approximately $3.0 million in charges ($2.0 million in after-tax charges, or $0.16 per share tax-effected), for the acceleration of stock awards, and approximately $324,000 in charges ($215,000 in after-tax charges, or $0.02 per share tax-effected), related to the discontinuation of the Company's embolic protection platform, both of which were incurred during the first quarter of fiscal 2008.

    Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA)
                      and Adjusted EBITDA Reconciliations

                          Six Months   Six Months
                            Ended        Ended         Year over Year
                         December 31, December 31,       % Change
                            2008          2007
                       ------------   ------------
    ($ millions)
    Net Income - GAAP      $10.5         $2.4
    Income Tax Expense       4.8          1.1
    Interest Income         (0.8)        (0.8)
    Interest Expense         1.0          0.4
    Depreciation and
     Amort
'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
2. Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference
3. Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
4. Kensey Nash to Present at the Canaccord Adams Small-Cap Orthopedics Conference
5. Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
6. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
7. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
8. Aerolase Reports Strong Sales in 2008 for Portable Aesthetic Lasers
9. GEN Reports on Growing Reliance on Microfluidics Technology
10. Novozymes Reports Strong 2008 Results
11. International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCools New Investigational UroCool System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Mass. , Aug. 20, 2014  Decision Resources Group finds ... , Russia , India ... $1.6 billion in 2013, roughly equal to the size of ... however, the BRIC market will experience much faster growth as a ... aging population. Other key findings from Decision Resources Group,s ...
(Date:8/20/2014)... 2014 The 6th Annual Arrowhead ... on October 29-30 in San Francisco, CA. This year’s ... government researchers and clinicians focused on addressing and solving ... In the twelve years since the sequencing of the ... introduced with pharmacogenetic information in the label and molecular ...
(Date:8/20/2014)... Aug. 20, 2014 /PRNewswire-iReach/ -- A case study ... between the school,s bioengineering department and the Intel® ... Intel® Software Academic Program, UCSD,s research focuses on ... human body.  Photo - ... the work of Dr. Todd P. Coleman ...
(Date:8/20/2014)... NJ (PRWEB) August 20, 2014 WriteResult®, ... announced today that it has expanded its myPROpad™ ePRO ... the EQ-5D-5L, one of the most widely used ... measuring general health status. The EQ-5D is used during ... generate a measure that can be used to demonstrate ...
Breaking Biology Technology:BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 36th Annual Personalized and Precision Medicine Conference Bringing Together Thought Leaders to Discuss Clinical Implementation, Dx Reimbursement, Big Data, and Sequencing 2Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research 2EQ-5D™ Assessment Now Available for iPad 2
... AUCKLAND, New Zealand, Jan. 6 MicroDose Technologies, ... have entered into a collaboration to investigate the ... generation electronic dry powder inhaler (DPI). Under ... the development of prototypes based upon MicroDose,s inhaler ...
... leader in providing automated, molecular testing solutions, announced today ... to present at the JPMorgan Healthcare Conference, which will ... Francis Hotel in San Francisco, CA. At this conference, ... of the Company at 11:00am on Tuesday, January 13, ...
... in drug-eluting stent technologyNATICK, Mass., Jan. 6 ... today announced that it has acquired Labcoat Limited, ... located in Galway, Ireland. Terms of the ... technology for coating drug-eluting stents that uses precisely ...
Cached Biology Technology:MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDose's Electronic Dry Powder Inhaler 2MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDose's Electronic Dry Powder Inhaler 3Boston Scientific Acquires Labcoat Limited 2Boston Scientific Acquires Labcoat Limited 3Boston Scientific Acquires Labcoat Limited 4
(Date:8/21/2014)... A study recently published in the journal ... shows a new role for the protein adenomatous polyposis ... cause of cancer-related deaths in the U.S. , Lead ... Molecular Biosciences and co-leader of the Cancer Biology program ... part of her career trying to understand the various ...
(Date:8/21/2014)... pancreatitis involves the pancreas digesting itself resulting in severe ... the UK around 20,000 patients are diagnosed with the ... cure and treatment is restricted to intravenous fluid and ... Faculty of Life Sciences, who led the research, said ... from gall stones and excessive alcohol intake combined with ...
(Date:8/20/2014)... , Aug. 20, 2014 /CNW/ -  Issue ... and can quickly become life threatening for some children.    ... as 1.2 million Canadians have food allergies and this number ... cent of children are estimated to have food allergies.  ... mild skin irritations and hives to breathing difficulties and loss ...
Breaking Biology News(10 mins):Research offers insight into cellular biology of colorectal cancer 2Research offers insight into cellular biology of colorectal cancer 3Insulin offers new hope for the treatment of acute pancreatitis 2Information Update - Allergens and food safety at school - What's in your child's lunch? 2Information Update - Allergens and food safety at school - What's in your child's lunch? 3
... Network(R) Video Reports , , ... , April 27 The U.S. Supreme Court has denied the ... Richard I. Fine who has never been charged with ... in L.A. County Central Men,s jail for over a year.  Fine attempted to ...
... 2010 Dominio Amigo S.A.S , a .CO,accredited domain name registrar, ... , , ... , CEO, Dominio Amigo S.A.S , commented, "Domainmonster was a,simple choice for ... gTLD launches, securing the very best Internet real estate,for their customers." "With a ...
... NEW BERN, N.C. , April 27 A hurricane ... your business, information, because you really haven,t thought about it until now. ... Atlantic region, now,s the time to update your document storage plans so ... , , ...
Cached Biology News:U.S. Supreme Court Allows 'Coercive Confinement' to Continue in Attorney's Civil Contempt Case 2U.S. Supreme Court Allows 'Coercive Confinement' to Continue in Attorney's Civil Contempt Case 3Dominio Amigo Announce Domainmonster as .CO Technical Partner 2Dominio Amigo Announce Domainmonster as .CO Technical Partner 3Hurricane-Proof Your Information 2
...
... Certified USDA Research Registered OLAW Assured AAALAC ... AALAS Certified Technicians Documentation ... Upon Request Focus CRP is ... your custom immunology service needs. We ...
... OrientExpress™ System Modules ... synthesis and directional cloning ... T7 expression vectors ... configuring OrientExpress™ Cloning Systems, ...
...
Biology Products: